View Item 

Show simple item record

One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Non-Alcoholic Steatohepatitis: A Pilot Study

dc.contributor.authorHuang, Mary Annen_US
dc.contributor.authorGreenson, Joel K.en_US
dc.contributor.authorChao, Cewinen_US
dc.contributor.authorAnderson, Lilianen_US
dc.contributor.authorPeterman, Debraen_US
dc.contributor.authorJacobson, Jonen_US
dc.contributor.authorEmick, Dawn M.en_US
dc.contributor.authorLok, Anna Suk-Fongen_US
dc.contributor.authorConjeevaram, Hari S.en_US
dc.date.accessioned2010-06-01T19:38:21Z
dc.date.available2010-06-01T19:38:21Z
dc.date.issued2005-05en_US
dc.identifier.citationHuang, Mary Ann; Greenson, Joel K.; Chao, Cewin; Anderson, Lilian; Peterman, Debra; Jacobson, Jon; Emick, Dawn; Lok, Anna S.; Conjeevaram, Hari S. (2005). "One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Non-Alcoholic Steatohepatitis: A Pilot Study." The American Journal of Gastroenterology 100(5): 1072-1081. <http://hdl.handle.net/2027.42/72774>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72774
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15842581&dopt=citationen_US
dc.format.extent232551 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing, Inc.en_US
dc.rights2005 by the American College of Gastroenterologyen_US
dc.titleOne-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Non-Alcoholic Steatohepatitis: A Pilot Studyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastroenterology, Department of Internal Medicine; Department of Pathology; General Clinical Research Center; Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michiganen_US
dc.identifier.pmid15842581en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72774/1/j.1572-0241.2005.41334.x.pdf
dc.identifier.doi10.1111/j.1572-0241.2005.41334.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceKumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 2000; 75 ( 7 ): 733 – 9.en_US
dc.identifier.citedreferenceSheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126 ( 2 ): 137 – 45.en_US
dc.identifier.citedreferenceLudwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55 ( 7 ): 434 – 8.en_US
dc.identifier.citedreferenceMarrero JA, Fontana RJ, Su GL, et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002; 36 ( 6 ): 1349 – 54.en_US
dc.identifier.citedreferenceMatteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116 ( 6 ): 1413 – 9.en_US
dc.identifier.citedreferencePowell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11 ( 1 ): 74 – 80.en_US
dc.identifier.citedreferenceChitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35 ( 2 ): 373 – 9.en_US
dc.identifier.citedreferencePagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35 ( 2 ): 367 – 72.en_US
dc.identifier.citedreferenceLuyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22 ( 3 ): 222 – 6.en_US
dc.identifier.citedreferenceWang RT, Koretz RL, Yee HF, JrS. Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med 2003; 115 ( 7 ): 554 – 9.en_US
dc.identifier.citedreferenceRanlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 1990; 47 ( 4 ): 208 – 14.en_US
dc.identifier.citedreferenceAndersen T, Gluud C, Franzmann MB, et al. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991; 12 ( 2 ): 224 – 9.en_US
dc.identifier.citedreferenceUeno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27 ( 1 ): 103 – 7.en_US
dc.identifier.citedreferenceNeuschwander-Tetri BA, Brunt EM, Wehmeier KR, et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 2003; 38 ( 4 ): 1008 – 17.en_US
dc.identifier.citedreferencePromrat K, Lutchman G, Uwaifo GI, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004; 39 ( 1 ): 188 – 96.en_US
dc.identifier.citedreferenceReaven GM. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 1997; 8 ( 1 ): 23 – 7.en_US
dc.identifier.citedreferencePouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73 ( 7 ): 460 – 8.en_US
dc.identifier.citedreferenceKatznelson L, Rosenthal DI, Rosol MS, et al. Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism. Am J Roentgenol 1998; 170 ( 2 ): 423 – 7.en_US
dc.identifier.citedreferenceKugelmas M, Hill DB, Vivian B, et al. Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 38 ( 2 ): 413 – 9.en_US
dc.identifier.citedreferenceHickman IJ, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004; 53 ( 3 ): 413 – 9.en_US
dc.identifier.citedreferenceCaldwell SH, Hespenheide EE, Redick JA, et al. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol 2001; 96 ( 2 ): 519 – 25.en_US
dc.identifier.citedreferenceKnowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346 ( 6 ): 393 – 403.en_US
dc.identifier.citedreferenceGoodpaster BH, Kelley DE, Wing RR, et al. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999; 48 ( 4 ): 839 – 47.en_US
dc.identifier.citedreferenceRoss R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000; 133 ( 2 ): 92 – 103.en_US
dc.identifier.citedreferenceRoss R, Janssen I. Physical activity, total and regional obesity: Dose-response considerations. Med Sci Sports Exerc 2001; 33 ( 6 Suppl ): S521 – 7 ( Discussion S528–9 ).en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1572-0241.2005.41334.x.pdf
Size:
227.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.